Gabriel Cabot

Pseudomonas aeruginosa Ceftolozane-Tazobactam Resistance Development Requires Multiple Mutations Leading to Overexpression and Structural Modification of AmpC

Gabriel Cabot, Sebastian Bruchmann, Xavier Mulet et al. · Antimicrobial Agents and Chemotherapy · 2014 · 239 citations · Full text

Molecular Biology, Antimicrobial Chemotherapy, Antibiotic Resistance +22

Genetic Markers of Widespread Extensively Drug-Resistant Pseudomonas aeruginosa High-Risk Clones

Gabriel Cabot, Alain A. Ocampo-Sosa, M.Á. Domínguez et al. · Antimicrobial Agents and Chemotherapy · 2012 · 221 citations · Full text

Genetics, Antibiotic Resistance, Drug Resistance +17

Influence of Virulence Genotype and Resistance Profile in the Mortality of Pseudomonas aeruginosa Bloodstream Infections

Carmen Peña, Gabriel Cabot, Sílvia Gómez-Zorrilla et al. · Clinical Infectious Diseases · 2014 · 218 citations · Full text

Overexpression of AmpC and Efflux Pumps in Pseudomonas aeruginosa Isolates from Bloodstream Infections: Prevalence and Impact on Resistance in a Spanish Multicenter Study

Gabriel Cabot, Alain A. Ocampo-Sosa, Fé Tubau et al. · Antimicrobial Agents and Chemotherapy · 2011 · 214 citations · Full text

Medical Microbiology, Antimicrobial Resistance Gene, Pseudomonas Aeruginosa Isolates +15

Evolution of Pseudomonas aeruginosa Antimicrobial Resistance and Fitness under Low and High Mutation Rates

Gabriel Cabot, Laura Zamorano, Bartolomé Moyá et al. · Antimicrobial Agents and Chemotherapy · 2016 · 205 citations · Full text